Clinical Trials in the Category "Colorectal Neoplasms"
Drug Intervention Trials that are Recruiting
Study Title |
Principal Investigator | Disease Category | |
 |
|||
| Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer |
Dr Andrew Shelton |
Rectal Cancer
Colorectal Neoplasms Anal, Colon, and Rectal Cancers | |
|
|||
| Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project |
Dr Andrew Quon |
Colorectal Neoplasms
Anal, Colon, and Rectal Cancers | |
|
|||
| Phase I Vandetanib plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer |
Branimir I Sikic |
Colorectal Neoplasms
Anal, Colon, and Rectal Cancers | |
|
|||
Other Trials that are Recruiting
| Study Title |
Principal Investigator | Disease Category | |
|
|||
| Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors |
Kate R Lorig |
Breast Cancer
Prostatic Neoplasms Colorectal Neoplasms Anal, Colon, and Rectal Cancers Blood Cancer | |
|
|||
| Clinical and Pathologic Studies of Patients Undergoing Treatment with EGFR Inhibitors |
George Albert Fisher M.D. Ph.D. Russell Pachynski |
Head and Neck Cancer
Colorectal Neoplasms Anal, Colon, and Rectal Cancers Colonic Neoplasms Lung Cancer Colon Cancer | |
|
|||
| QOL & Functional Outcomes After Combined Modality Tx for Anal CA: Comparison of Conventional vs IMRT |
Mark Lane Welton |
Anal Cancer | |
|
|||
| Assessment of Health Related Quality of Life in Patients Treated for Rectal Cancer |
Mark Lane Welton |
Rectal Cancer | |
|
|||
| Molecular Genetic and Pathological Studies of Anal Tumors |
Mark Lane Welton |
Rectal Cancer
Anal Cancer Colonic Neoplasms Colon Cancer | |
|
|||
Trials not Recruiting
| Study Title |
Principal Investigator | Disease Category | |
|
|||
|
Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
(Suspended) |
Harlan Pinto |
Colonic Neoplasms
Colon Cancer | |
|
|||
|
Metabolic Imaging Predict Histopathologic Response to Preop ChemoXRT for Locally Advanced Rectal CA
(Terminated) |
Albert Koong |
Rectal Cancer | |
|
|||
|
Safety Study of Cetuximab in combination with Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer
(Completed) |
George Albert Fisher M.D. Ph.D. Branimir I Sikic |
Rectal Cancer | |
|
|||
| The physicians of the Stanford Cancer Center are engaged in more than 250 clinical trials. Contracts with some of our clinical trial sponsors prevent us from listing specific trial information on our web site. Please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 for information about additional open clinical trials. |
Trial Administration